Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stereotaxis (STXS)
:STXS
Holding STXS?
Track your performance easily
Earnings Data
Report Date
Mar 18, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.07Last Year’s EPS
-0.07Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2018
|% Change Since: 12.43%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and successful integration of APT, alongside promising developments in product innovation, particularly in the European market. However, challenges remain in the U.S. and China markets due to delayed regulatory approvals, and there were notable operating losses. The sentiment is balanced by strong progress and future potential, tempered by current financial and regional challenges.Company Guidance
During the Stereotaxis Q3 2024 earnings call, David Fischel, the CEO, discussed several key metrics and forward-looking statements. The company reported revenue of $9.2 million for the quarter, an 18% increase year-over-year, driven by partial revenue recognition on three Genesis systems delivered to European hospitals. Stereotaxis received orders for two additional Genesis systems, resulting in a capital backlog of $15.5 million. Recurring revenue was bolstered by a $0.5 million contribution from APT catheter sales, acquired recently, with expectations for continued sequential growth. Gross margin was reported at 45%, with system gross margin at 16% and recurring revenue gross margin at 70%. The company maintained its revenue guidance, anticipating year-over-year growth in both system and recurring revenue. Looking ahead, Stereotaxis is focused on regulatory approvals for its MAGIC catheter and GenesisX systems, expecting significant contributions to growth from these innovations. The company ended the quarter with $11 million in cash and no debt, projecting a year-end cash balance of approximately $12 million.Revenue Growth
Third quarter 2024 revenue totaled $9.2 million, an 18% year-over-year increase compared to $7.8 million in the prior year third quarter.
Genesis System Orders
Received orders for 2 additional Genesis systems in the third quarter, contributing to a capital backlog of $15.5 million.
Successful APT Acquisition
The acquisition of APT contributed approximately $0.5 million in catheter revenue in the third quarter, with expectations for larger contributions in the fourth quarter.
Advanced Innovation Strategy
Significant progress on new product ecosystems, including nearing CE Mark approval for the MAGIC catheter and development of robotic high-density mapping and vascular guidance catheters.
Strong European Market
Capital results predominantly driven by Europe with an advanced product ecosystem and regulatory approvals.
---
STXS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STXS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 11, 2024 | $1.85 | $2.26 | +22.16% |
| Aug 12, 2024 | $1.80 | $2.01 | +11.67% |
| May 13, 2024 | $2.16 | $2.09 | -3.24% |
| Mar 04, 2024 | $2.61 | $2.43 | -6.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Stereotaxis (STXS) report earnings?
Stereotaxis (STXS) is schdueled to report earning on Mar 18, 2025, TBA Not Confirmed.
What is Stereotaxis (STXS) earnings time?
Stereotaxis (STXS) earnings time is at Mar 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STXS EPS forecast?
STXS EPS forecast for the fiscal quarter 2024 (Q4) is -0.07.
---